Halozyme Therapeutics: which funds own it
A 13F shows the portfolio at quarter-end and is filed up to 45 days later: these are not real-time positions and they may have changed.
Sections with a free account
No concentrated manager holds it.
Quarter flow (concentrated managers)
Concentrated managers holding it
None in the latest quarter.
Largest holders (all 13F filers)
- TPG Gp A10.0 MPrivate equity or venture capital0
- Rational Advisors5.1 MType not verified+2.1 M
- Focus Partners Wealth3.7 MWealth adviser−40 K
- Oppenheimer Asset Management173 KType not verified+3,000
- &partners130 KType not verified0
- Mariner59 KWealth adviser0
- Stephens53 KType not verified0
- Commonwealth Equity Services17 KWealth adviser−3,000
- Cetera Investment Advisers12 KWealth adviser0
- Lanark Financial8,000Type not verified+8,000
- Shares
- 10.0 M
- Change
- 0
See more
- Type
- Private equity or venture capital
- Value
- $11.1M
- Rational Advisors
- Shares
- 5.1 M
- Change
- +2.1 M
See more
- Type
- Type not verified
- Value
- $5.7M
- Shares
- 3.7 M
- Change
- −40 K
See more
- Type
- Wealth adviser
- Value
- $4.1M
- Shares
- 173 K
- Change
- +3,000
See more
- Type
- Type not verified
- Value
- $192K
- Shares
- 130 K
- Change
- 0
See more
- Type
- Type not verified
- Value
- $144K
- Shares
- 59 K
- Change
- 0
See more
- Type
- Wealth adviser
- Value
- $65.7K
- Shares
- 53 K
- Change
- 0
See more
- Type
- Type not verified
- Value
- $58.9K
- Shares
- 17 K
- Change
- −3,000
See more
- Type
- Wealth adviser
- Value
- $18.9K
- Shares
- 12 K
- Change
- 0
See more
- Type
- Wealth adviser
- Value
- $13.3K
- Shares
- 8,000
- Change
- +8,000
See more
- Type
- Type not verified
- Value
- $8.9K
The 10 13F filers with the most shares as of Jun 30, 2026, whatever their type (index firms usually come first). “Change”: shares added or cut versus the previous quarter, split-adjusted; “no data” = there is no comparable portfolio for the previous quarter (no filing, or a filing with its holdings under confidential treatment). “% of the company” only where shares outstanding are up to date. Entities of the same group file separately and some 13F filings include other managers: there may be double counting. With a free account: the top 25, the largest buyers and the largest sellers.
Insiders (Form 4)
Open-market purchases, excluding 10b5-1 plans. Officers and directors only; joint filers of the same purchase count as one. 10% owners with no role are shown separately. 0 = nobody bought; “no data” = we do not have its Form 4 filings.
Above 5% (13D/13G)
This list may be incomplete: we hold 13D and 13G filings made since December 2024. A holder above 5% that has not filed anything since then is not shown here.
No recent filings.
All material events (8-K)
Earnings, agreements, financing, management changes and announcements from the last year, with a filter by type and a link to each filing.